Related Experiment Video
Updated: Jul 16, 2026

08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Neuropathological evaluation of mixed dementia
1Institute of Clinical Neurobiology, 18, Kenyongasse, A-1070 Vienna, Austria. kurt.jellinger@univie.ac.at
Journal of the Neurological Sciences
|February 28, 2007
Summary
Mixed dementia, combining Alzheimer disease and vascular issues, presents diagnostic challenges. Autopsy studies reveal frequent co-occurrence, highlighting the need for better diagnostic criteria for mixed dementia.
Area of Science:
- Neurology
- Pathology
- Gerontology
Background:
- Mixed dementia (MD) involves co-occurring Alzheimer disease (AD) and vascular encephalopathy, with controversial diagnostic distinctions.
- Current criteria for MD use clinical/neuroimaging findings of AD and cerebrovascular disease (CVD), but causal links remain unclear.
- Proposed diagnostic criteria for MD combine autopsy-proven AD with significant vascular or ischemic brain lesions.
Purpose of the Study:
- To investigate the prevalence and pathological characteristics of mixed dementia (MD).
- To evaluate the coexistence of Alzheimer disease (AD) and cerebrovascular lesions in elderly demented subjects.
- To discuss the pathogenic factors and diagnostic limitations in differentiating AD, vascular dementia (VaD), and MD.
Main Methods:
- Retrospective and prospective autopsy studies were conducted on demented elderly subjects.
- Analysis included a series of 1500 demented individuals, with 830 having clinically probable AD.
- Histopathological examination assessed AD, vascular lesions, and other dementing pathologies.
Main Results:
- Mixed dementia (MD) prevalence in autopsy studies ranged from 2% to 58% (mean 6-12%).
- In a Vienna series, MD was diagnosed in 2.4-4.6% of cases, while pure AD was 41.5-52.0% and pure VaD was 2.0-11%.
- Vascular lesions were common in AD and VaD (subcortical/microinfarcts), but large/hemispheral infarcts were more frequent in MD, suggesting distinct pathogenetic mechanisms.
Conclusions:
- Alzheimer disease (AD) and cerebrovascular lesions frequently coexist in cognitively impaired patients.
- Distinct pathological patterns in AD, VaD, and MD suggest different underlying pathogenic mechanisms.
- Current clinico-pathological criteria for diagnosing VaD and MD are insufficient, necessitating development of validated histopathological criteria.
Related Concept Videos
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

